Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Zolmitriptan:MCnc:Pt:Bld:Qn

Known as: ????:????:???:??:???, Zolmitriptan:Masse/Volume:Ponctuel:Sang:Numérique, Zolmitriptan:Massa concentratie:Moment:Bloed:Kwantitatief 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract Enhancement of zolmitriptan bioavailability through development of micronized zolmitriptan pressurized metered dose… Expand
2019
2019
Abstract Objective: Novel niosomal formulation may be successfully applied to treat a systemic disease such as migraine through… Expand
2016
2016
Lung imaging radiopharmaceuticals are helpful agents for measuring pulmonary blood flow and allow detection of pulmonary embolism… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
2016
2016
The objective of the present work was to carry out systematic evaluation to eliminate matrix effect owing to plasma phospholipids… Expand
2013
2013
  • J. Liu, X. Zhou
  • Journal of chromatographic science
  • 2013
  • Corpus ID: 206376873
The objective of this work was to develop a simple, cost effective, rugged and rapid method for the simultaneous estimation of… Expand
  • figure 1
  • figure 2
  • table I
  • figure 3
  • table II
Highly Cited
2005
Highly Cited
2005
The aim of this investigation was to prepare microemulsions containing zolmitriptan (ZT) for rapid drug delivery to the brain to… Expand
2005
2005
A gradient, reversed-phase liquid chromatographic (RP-LC) assay method was developed for the quantitative determination of… Expand
  • table 1
  • figure 2
  • figure 3
  • table 4
2005
2005
AbstractObjective: Triptans are highly effective in the treatment of migraine. Both central and peripheral mechanisms of action… Expand
1999
1999
1. Zolmitriptan was extensively metabolized by freshly isolated human hepatocytes to a number of components including the three… Expand
Highly Cited
1999
Highly Cited
1999
5-Hydroxytryptamine (5-HT) can produce both vasoconstrictor and vasorelaxant effects in human coronary arteries and the response… Expand